Molecular imaging in Parkinsonism: The essential for clinical practice and future perspectives.
Rev Neurol (Paris)
; 178(5): 484-489, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35527085
ABSTRACT
Nuclear medicine with positron emission tomography (PET) and single photon emission computed tomography (SPECT) develops powerful tools in molecular imaging to help clinicians in the challenging diagnosis of parkinsonism. These techniques can provide biomarkers for neurodegenerative parkinsonism and to distinguish Parkinson disease (PD) from atypical parkinsonism. This review summarizes the main SPECT and PET contributions to the diagnosis of parkinsonism. We will also discuss new technologies in the field of nuclear imaging and their potential contribution to the diagnosis of parkinsonian syndromes.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Parkinsonian Disorders
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Rev Neurol (Paris)
Year:
2022
Document type:
Article